TYP
Tryptamine Therapeutics Limited
🇦🇺 ASX
📦 LOGISTICS
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-17.38%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
4
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Tryptamine Therapeutics Ltd is a AU-based company operating in Pharmaceuticals industry. Tryptamine Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The firm is focused on the development of an advanced and scalable intravenous-infused psilocin formulation, which can be used in conjunction with psychotherapy to address significant unmet medical needs. The company is focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. The company intends to accomplish this through the development of an IV infusion of psilocin (the active metabolite of psilocybin). Its lead programs are designed to address neuropsychiatric disorders through the therapeutic dosing of synthetic psilocybin and IV infused psilocin in conjunction with psychotherapy. The firm is engaged in pursuing Phase II clinical trials using its psilocybin and psilocin-based drug products for chronic pain and eating disorders. The firm's pipeline products include TRP-8803 and TRP-8802.
📈 Performance
Price History
-81.00%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.04
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in TYP
4
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
35 weeks
💵 Average investment amount
$1,700
⏰ Last time a customer invested in TYP
41 days
TYP investor breakdown
💵 Income of investors
More than 200k
150k - 200k
17%
100k - 150k
17%
50k - 100k
17%
Less than 50k
50%
👶 Age of investors
18 - 25
25%
26 - 34
25%
35 - 90
50%
🙋 Legal gender of investors
Female
Male
100%
Pearlers who invest in TYP also invest in...
IMPQ.AX was created on 2021-09-29 by Perennial. The fund's investment portfolio concentrates primarily on total market equity. The objective of the Fund is to deliver long-term capital growth predominately through investments in Australian and New Zealand listed smaller and mid-cap companies that are Better Future Investments.
🙌 Performance (5Yr p.a)
1.16%
📊 Share price
$4.92 AUD
VISM.AX was created on 2018-11-09 by Vanguard. The fund's investment portfolio concentrates primarily on small cap equity. The Vanguard MSCI International Small Companies Index ETF seeks to track the return of the MSCI World ex-Australia Small Cap Index in Australian dollars, before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.67%
📊 Share price
$68.17 AUD
⛳️ DIVERSIFIED
🌏 GLOBAL
VEU.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard All-World ex-US Shares Index ETF seeks to track the return of the FTSE All-World ex US Index before taking into account fees, expenses and tax
🙌 Performance (5Yr p.a)
4.61%
📊 Share price
$96.62 AUD
⛳️ DIVERSIFIED
🌏 GLOBAL
EMKT.AX was created on 2018-04-10 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The VanEck MSCI Multifactor Emerging Markets Equity ETF (EMKT.AX) invests in a diversified portfolio of emerging markets listed securities with the aim of providing investment returns, before fees and other costs, which track the performance of the MSCI Emerging Markets Diversified MultipleFactor Index (AUD) (EMKT.AX Index).
🙌 Performance (5Yr p.a)
6.09%
📊 Share price
$26.46 AUD
🤖 TECHNOLOGY
🌏 GLOBAL
ESGI.AX was created on 2018-03-06 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.
🙌 Performance (5Yr p.a)
8.11%
📊 Share price
$36.79 AUD
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
🌏 GLOBAL
Want more shares? Try these...
Tyro Payments Ltd. engages in the provision of merchant credit, debit and EFTPOS acquisition services. The company is headquartered in Sydney, New South Wales and currently employs 626 full-time employees. The company went IPO on 2019-12-06. The firm is focused on providing Australian businesses with payment solutions and complementary business banking products. The firm provides credit, debit and electronic funds transfer at point of sale (EFTPOS) card acquiring, Medicare and private health fund claiming and rebating services to Australian businesses. The company takes money on deposit and offers unsecured cash-flow based lending to Australian EFTPOS merchants. The firm is focused on in-store payments through e-Commerce solutions. The company also provides solutions, such as its loans in the form of merchant cash advances and its fee-free, interest-bearing merchant transaction accounts and term-deposit accounts. The company offers Tyro Connect, which is an integration hub for applications and point of sale (POS) systems, a plug and play platform software solution. Its segments include Payments and Banking.
🙌 Performance (5Yr p.a)
-15.77%
📊 Share price
$0.86 AUD
💸 FINANCIALS
